Effect of Tebipenem on Normal Human Intestinal Microbiota

Clinical trial NCT04376554 · COMPLETED

Trial details

NCT number: NCT04376554
Sponsor: Spero Therapeutics
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Volunteers

Start date: 2020-02-10
Primary completion: 2021-04-06
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.